Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Ogunseinde BA et al. |
A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. |
2003 |
Transplantation |
pmid:12883222
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Kee TY et al. |
Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. |
2006 |
Transplantation |
pmid:16861939
|
Pascual J et al. |
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. |
2006 |
Transplantation |
pmid:16861942
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Leroy-Matheron C et al. |
Inhibitor against coagulation factor V after liver transplantation. |
1999 |
Transplantation |
pmid:10532550
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Chaftari AM et al. |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. |
2012 |
Transplantation |
pmid:22814329
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Jeske HC et al. |
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat. |
2003 |
Transplantation |
pmid:14557751
|
Tsuchiya T et al. |
Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus. |
2013 |
Transplantation |
pmid:23792649
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Hilbrands R et al. |
Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. |
2013 |
Transplantation |
pmid:23857001
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Kihm LP et al. |
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. |
2012 |
Transplantation |
pmid:22470107
|
Hoogtanders K et al. |
Dried blood spot measurement of tacrolimus is promising for patient monitoring. |
2007 |
Transplantation |
pmid:17264824
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Lang T et al. |
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. |
1996 |
Transplantation |
pmid:8824477
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Sato T et al. |
Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. |
2003 |
Transplantation |
pmid:14627910
|
Hooper DK et al. |
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantation. |
2012 |
Transplantation |
pmid:22491658
|
Sarwal MM et al. |
Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. |
2003 |
Transplantation |
pmid:14627912
|
Ciancio G et al. |
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. |
2008 |
Transplantation |
pmid:18622280
|
Vignali D et al. |
IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. |
2016 |
Transplantation |
pmid:27306531
|
Arroyo Hornero R et al. |
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. |
2017 |
Transplantation |
pmid:28118317
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
De Ruvo N et al. |
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation. |
2005 |
Transplantation |
pmid:16003226
|
Reich DJ et al. |
Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. |
2005 |
Transplantation |
pmid:16003228
|
Guasch A et al. |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. |
2010 |
Transplantation |
pmid:20811320
|
Wennberg L et al. |
Preapheresis immunosuppressive induction: necessary or harmful? |
2007 |
Transplantation |
pmid:18162987
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
Azzola A et al. |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. |
2004 |
Transplantation |
pmid:14742993
|
Hewitt CW and Black KS |
Comparative studies of FK506 with cyclosporine. |
1988 |
Transplantation |
pmid:2458644
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Hoerning A et al. |
Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. |
2015 |
Transplantation |
pmid:25099702
|
Yilmaz MI et al. |
Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. |
2005 |
Transplantation |
pmid:16378057
|
Zhang W et al. |
Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation. |
2017 |
Transplantation |
pmid:28885495
|
Guitard J et al. |
Predictive factors for anemia six and twelve months after orthotopic liver transplantation. |
2006 |
Transplantation |
pmid:16770241
|